TREACE JOHN T. (Chief Executive Officer) purchased 0.9% of their position (60K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $524.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/4/2025ACC: 0000950170-25-032626
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+60K
Net shares
Net buyer
$524.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60K
Price / share
$8.73
Trade value
$524.06K
% of position
0.9%
3/4/2025
6.74M→6.80M
Total
Net shares
+60K
Net value
$524.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2025 | P · Purchase | +60K | $8.73 | $524.06K | 0.9% | 6.74M | 6.80M |
| Total | +60K | $524.06K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned1.60M
Common Stock
IndirectShares owned408.82K
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 1.60M | Indirect |
| Common Stock | 408.82K | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported